Andrew Reardon - Mar 24, 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Stock symbol
LGND
Transactions as of
Mar 24, 2023
Transactions value $
-$20,977
Form type
4
Date filed
3/28/2023, 05:00 PM
Previous filing
Feb 27, 2023
Next filing
Aug 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Sale -$21K -300 -1.81% $69.92 16.3K Mar 24, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Legal Officer and Secretary